Vitro Biopharma Revenues Increase in Early 2014: Plans Trials of Endogenous … – Yahoo News
|
Vitro Biopharma Revenues Increase in Early 2014: Plans Trials of Endogenous …
Yahoo News Vitro Biopharma continues development its stem cell-based products and services for drug discovery. We anticipate commercialization of an initial series of assays during the first half of 2014. These assays will include cell-based toxicology assays and … |
